By Craig Clough ( December 5, 2019, 11:05 PM EST) -- The founder of Kite Pharma on Thursday countered claims that he sought to license a Sloan Kettering-developed patent that Kite is accused of infringing, testifying to a California federal jury that he only pursued a meeting with a Sloan Kettering researcher to "get access to his patients," not his patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.